Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AOX1 | Q06278 | 1/20 | 1.00 |
| ▸ | ACHE | P22303 | 1/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA4 | P22748 | 1/20 | 0.38 |
| ▸ | CA5A | P35218 | 1/20 | 0.38 |
| ▸ | CA7 | P43166 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5488235 | 0.82 | AOX1 (0.70) | AOX1ACHEKCNH2MEN1KMT2A | |
| SCHEMBL27925108 | 0.79 | AOX1 (0.66) | AOX1ACHEKCNH2MEN1KMT2A | |
| SCHEMBL2515116 | 0.79 | AOX1 (0.66) | AOX1ACHEKCNH2MEN1KMT2A | |
| SCHEMBL777194 | 0.79 | AOX1 (0.66) | AOX1ACHEMEN1KMT2ANPSR1 | |
| SCHEMBL779739 | 0.78 | AOX1 (0.64) | AOX1ACHEKCNH2MEN1KMT2A | |
| SCHEMBL28068172 | 0.77 | AOX1 (0.62) | AOX1ACHEKCNH2MEN1KMT2A | |
| SCHEMBL28693406 | 0.77 | AOX1 (0.62) | AOX1NPSR1ALDH1A1MAPTGAA | |
| SCHEMBL28026572 | 0.77 | AOX1 (0.62) | AOX1ACHEKCNH2MEN1KMT2A | |
| SCHEMBL9340193 | 0.77 | AOX1 (0.62) | AOX1ACHEKCNH2MEN1KMT2A | |
| SCHEMBL9336390 | 0.75 | AOX1 (0.60) | AOX1ACHEKCNH2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115812635-B | EPP material vertical barrel-shaped intelligent bee-keeping box | 云南本季生物技术有限公司 | 2024-06-11 | — | — | CN | disclosed |
| CN-117529424-A | EPP foaming seat cushion with ventilation device | 舒茨曼座椅（宁波）有限公司 | 2024-02-06 | — | — | CN | disclosed |
| WO-2023050200-A1 | EPP FOAMED SEAT CUSHION WITH VENTILATION DEVICE | 舒茨曼座椅（宁波）有限公司 | 2023-04-06 | — | — | WO | disclosed |
| CN-115812635-A | Vertical tubbiness intelligent bee-keeping case of EPP material | 云南本季生物技术有限公司 | 2023-03-21 | — | — | CN | disclosed |
| CN-217778454-U | Anti-overflow material back-row seat integrated configuration | 长春富维安道拓汽车饰件系统有限公司 | 2022-11-11 | — | — | CN | disclosed |
| US-9026372-B2 | Methods for providing a system of care for a high-dose oxazaphosphorine drug regimen | ACCENTIA BIOPHARMACEUTICALS, INC. (US) | 2015-05-05 | — | — | US | disclosed |
| US-20110117050-A1 | Methods for Providing a System of Care for an Oxazaphosphorine Drug Regimen | ACCENTIA BIOPHARMACEUTICALS, INC. (US) | 2011-05-19 | — | — | US | disclosed |
| US-20110097426-A1 | Methods for Safe and Effective Treatment Using Oxazaphosphorine Drugs | ACCENTIA BIOPHARMACEUTICALS, INC. (US) | 2011-04-28 | — | — | US | disclosed |
| US-20110082115-A1 | Methods for Providing a System of Care for an Oxazaphosphorine Drug Regimen | ACCENTIA BIOPHARMACEUTICALS, INC. (US) | 2011-04-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110117050-A1 | Methods for Providing a System of Care for an Oxazaphosphorine Drug Regimen | PAICS, TYMP, OTC | AOX1 488/4885ACHE 158/4885KCNH2 3808/4885 |
| US-20110082115-A1 | Methods for Providing a System of Care for an Oxazaphosphorine Drug Regimen | PAICS, TYMP, OTC | AOX1 488/4885ACHE 158/4885KCNH2 3808/4885 |
| US-20110097426-A1 | Methods for Safe and Effective Treatment Using Oxazaphosphorine Drugs | TYMP, PAICS, ENTPD5 | AOX1 630/4885ACHE 154/4885KCNH2 2636/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.